Ascendis製藥 ASND 深 滬
交易中 09-19 13:01:02 美东时间
153.07
+4.190
+2.81%
華盛通- 最 高154.81
- 今 開151.00
- 成交量 50.03万股
- 最 低 149.26
- 昨 收 148.88
- 總市值 87.79亿
- 52周最高 161.00
- 市盈率 靜 --
- 換手率 0.87%
- 52周最低 85.285
- 委 比 66.67%
- 總股本 5735.04万
- 歷史最高 183.98
- 量 比 0.58
- 振 幅 3.73%
- 歷史最低 11.92
- 每 手 1
- 風險率 20.13%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Ascendis Pharma proposed public offering of ADSS
Ascendis Pharma A/S (ASND) commenced an underwritten public offering of $300M of American Depositary Shares, each of which represents one ordinary share of Ascendis. In addition, Ascendis expects to g...
09-19 04:17
Ascendis Pharma Commences Public Offering Of $300M Of ADSs
All of the ADSs are being offered by Ascendis. In addition, Ascendis expects to grant the underwriters a 30-day option to purchase up to an additional $45 million of ADSs at the public offering price, less the
09-19 04:05
快讯 | Ascendis Pharma A/S: Leerink Partners将目标价从165美元提高至185美元
Ascendis Pharma A/S : Leerink Partners Raises Target Price to $185 From $165
09-17 11:54
BioMarin off 17% as Ascendis data seen as threat to Voxzogo
BioMarin Pharmaceutical (NASDAQ:BMRN) is down ~17% Monday following positive data from an Ascendis Pharma (ASND) achondroplasia candidate that could challenge the former's Voxzogo. Data from the pivot...
09-17 02:59
Crude Oil Surges Over 1%; Instil Bio Shares Plunge
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite fall...
09-17 00:31
Alcoa, Lattice Semiconductor, Stratasys And Other Big Stocks Moving Higher On Monday
U.S. stocks were mixed, with the Dow Jones index gaining around 200 points on M...
09-16 22:03
Ascendis Pharma’s Growth Treatment Excels in Trial
Ascendis Pharma (ASND) has released an update. Ascendis Pharma’s TransCon CNP s...
09-16 19:57
Ascendis Pharma Reports Positive Trial Results
Ascendis Pharma (ASND) has released an update. Ascendis Pharma A/S has announce...
09-16 19:47
Ascendis Pharma Secures FDA Orphan Drug Exclusivity
Ascendis Pharma (ASND) has released an update. Ascendis Pharma A/S has announce...
09-12 18:29
Ascendis gets FDA orphan drug status for Yorvipath for hypothyroidism
The FDA has granted Orphan Drug Designation to Ascendis Pharma (ASND) for its prodrug Yorvipath for the treatment of hypothyroidism in adults. Yorvipath is also known as palopegteriparatide and was de...
09-12 06:07
